Main Structural Characteristics

In order to facilitate the structural definition for each class of Corporate Entities, the following main structural characteristics are defined:

  • Substances
    • Name - internal
    • International Non-Protected Name (INN)
    • Preferred invented name
    • Molecular weight
    • Empirical formula 
    • Chemical name
    • Origin
    • Role
    • Standard
  • Reference Medicinal Products
    • International Non-Protected Name (INN)
    • Dosage form
    • Active substance(s)
    • Strength
    • Legal status
    • Route of administration
    • Indication
    • Existing Marketing Authorization
    • Use of the Reference Medicinal Product
  • Organizations
    • General Data
    • Legal position in the Corporation
    • Legal position in relation to the Corporation
    • Certifications
  • Marketed Substances
    • Main Substance
    • Type of Standard
    • Role
    • Origin
    • Standard
    • Distributing Organization(s)
  • Pre-Clinical Tests
    • Innovative Active Substance
    • Type of Pre-Clinical Tests
    • Organizations and their roles
    • Indication(s)
    • Objectives
    • Investigational Sites
    • Marketed Substance Production Chain
    • Pre-Clinical Tests Design
  • Clinical Trials with Generic Investigational Medicinal Product(s)
    • Active Substance(s)
    • Reference Medicinal Product
    • Clinical Trial Classification
    • Organization(s) and their roles
    • Indication(s)
    • Objectives
    • Investigational Sites
    • Investigational Medicinal Product Preparation Production Chain(s)
    • Clinical Trial Design
  • Generic Investigational Medicinal Products
    • Reference Medicinal Product
    • Active Substance
    • Dosage Form
    • Strength
    • Route of administration
    • Indication
  • Generic Medicinal Products
    • Reference Medicinal Product
    • Active Substance
    • Dosage Form
    • Strength
    • ATC Code
    • Legal Status
    • Supply
    • Route of administration
    • Indication
  • Marketed Substance-Production Chains
    • Marketed Substance
    • Starting Material Production Chains
    • Manufacturing Operations/Organization
    • Containers
    • Shelf Life
  • Pre-Clinical Tests Dossiers
    • Active Substance
  • Generic Investigational Medicinal Product - Preparation Production Chains
    • Generic Investigational Medicinal Product
    • Leading Corporate Entity
    • Batch Size
    • Qualitative and Quantitative Composition
    • Manufacturing Operations/Organizations
    • Containers
    • Shelf Life
  • Generic Medicinal Product - Preparation Production Chains
    • Generic Medicinal Product
    • Leading Corporate Entity
    • Batch Size
    • Qualitative and Quantitative Composition
    • Manufacturing Operations/Organizations
    • Containers
    • Shelf Life
  • Medicinal Products Dossier - Generic Substance
    • Generic Active Substance
    • Marketing Authorization Domain
  • Clinical Trial with Innovative Investigational Medicinal Products
    • Active Substance(s)
    • Clinical Trial Classification
    • Organization(s) and their roles
    • Indication(s)
    • Objectives
    • Investigational Sites
    • Investigational Medicinal Product Preparation Production Chain(s)
    • Clinical Trial Design
  • Innovative Investigational Medical Product
    • Active Substance
    • Dosage Form
    • Strength
    • Route of administration
    • Indication
  • Innovative Investigational Medical Product - Preparation Production Chains
    • Innovative Investigational Medicinal Product
    • Leading Corporate Entity
    • Batch Size
    • Qualitative and Quantitative Composition
    • Manufacturing Operations/Organizations
    • Containers
    • Shelf Life
  • Clinical Trial Dossiers
    • Active Substance(s)
    • Reference Medicinal Product
    • Clinical Trial Classification
    • Organization(s) and their roles
    • Indication(s)
    • Objectives
    • Investigational Sites
    • Investigational Medicinal Product Preparation Production Chain(s)
    • Clinical Trial Design
  • Innovative Medicinal Products
    • Active Substance
    • Dosage Form
    • Strength
    • ATC Code
    • Legal Status
    • Supply
    • Route of administration
    • Indication
  • Innovative Medicinal Product - Preparation Production Chains
    • Generic Medicinal Product
    • Leading Corporate Entity
    • Batch Size
    • Qualitative and Quantitative Composition
    • Manufacturing Operations/Organizations
    • Containers
    • Shelf Life
  • Medicinal Products Dossier - Innovative Substance(s)
    • Innovative Active Substance(s)
    • Marketing Authorization Domain
  • Marketing Campaign - OTC Medicinal Product(s)
    • Active Substance(s)
    • Medicinal Products
    • Marketing Promotional Material-Production Chain
    • Participating Organizations
  • Marketing Promotional Material-Production Chain - OTC Medicinal Product(s)
    • Marketing Promotional Material
    • Production Operation/Organization
  • Marketing Campaign Dossiers - OTC Medicinal Product(s)
    • Active Substance
    • Marketing Domain

Among other uses, the main structural characteristics of Corporate Entities are used in Enriched Email Client as a subtopic to facilitate data gathering during the structural and narrative definition processes.